Open | $1.550 |
Close | $1.500 |
Volume / Avg. | 56.989K / 130.779K |
Day Range | 1.490 - 1.550 |
52 Wk Range | 0.680 - 4.580 |
Market Cap | $43.626M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 3.59% |
Days to Cover | 9.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DarioHealth (NASDAQ: DRIO) through any online brokerage.
Other companies in DarioHealth’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX), Trxade Health (NASDAQ:MEDS) and TruBridge (NASDAQ:TBRG).
The latest price target for DarioHealth (NASDAQ: DRIO) was reported by Alliance Global Partners on Friday, August 11, 2023. The analyst firm set a price target for 4.10 expecting DRIO to rise to within 12 months (a possible 161.15% upside). 3 analyst firms have reported ratings in the last year.
The stock price for DarioHealth (NASDAQ: DRIO) is $1.57 last updated March 18, 2024 at 9:19 AM EDT.
There are no upcoming dividends for DarioHealth.
DarioHealth’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for DarioHealth.
DarioHealth is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.